BRK-B vs QQQX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The fund exhibits a critical Piotroski F-Score of 1/9, indicating severe fundamental weakness by deterministic standards, although this is typical for closed-end fund structures. While historical price performance is strong (1Y +43.7%), the asset is currently trading at a premium to its intrinsic value of $26.25. A stark divergence exists between the near-52-week high price and a very bearish technical trend score of 10/100. The primary attraction remains the robust 8.32% dividend yield, which provides a significant income cushion.
Compare Another Pair
Related Comparisons
BRK-B vs QQQX: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen Nasdaq 100 Dynamic Overwrite Fund (QQQX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.